English (United Kingdom)Русский (Russian Federation)

Clinical services

Cromos Pharma can manage both single- and multi-center phase I-IV trials in a wide range of therapeutic areas. We also provide services on conduction of bioequivalence studies.

Our project management team is proactive, with effective communication across the spectrum. Responsibilities, processes and reporting lines are clearly defined at an early stage. These procedures are approved step by step to ensure complete transparency.

The primary point of contact will be the Project Manager who will give your study absolute priority, ensuring that timelines are met, quality is maintained, appropriate training is delivered and the budget is adhered to.

Experienced physicians monitor our clinical trials. They are citizens of respective countries, fluent in English and have good knowledge of the local medical community and of therapeutic standards. Our CRAs have undergone extensive training to ensure complete ICH GCP understanding and have industry-related experience of 2-5 years and research experience of at least 2 years.  Their selection is based on both level of experience and professional capabilities.

While working with us you can be sure that CRA assigned to your study will not be replaced by another CRA (except for insurmountable obstacles). It is our policy to keep the same CRA for the lifetime of your study.

We also have a dedicated staff available 24/7 to reply to your requests regarding study and to support investigators.

Our CRAs also can conduct unblinded pharmacy monitoring visits.

If you are interested in clinical research services provided by our company, just This e-mail address is being protected from spambots. You need JavaScript enabled to view it or call Dr. Vladimir Krechikov.

 
News and messages from CEO,
Dr Vladimir Bogin
12.01.2012

Cromos Pharma has participated in the conference on clinical trials in emerging markets in Tel-Aviv, Israel on 11 January 2012.

[...]

05.01.2012

Meet Cromos Pharma's CEO, Dr. Vladimir Bogin at the 30th JP Morgan Healthcare Conference in San Francisco, CA on 9-12 January 2012.

[...]

14.12.2011

Cromos Pharma published a white paper with review of Russian clinical trials market in 2011.

[...]

28.10.2011

Cromos Pharma's CEO, Dr. Vladimir Bogin has participated in the annual Rusnanotech forum in Moscow, Russia on 25-28 October 2011 .

[...]

27.09.2011

Meet us at 17th Annual International Partnering Conference BIO-Europe 2011 in Duesseldorf, Germany on 31 October - 02 November 2011.

[...]